📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The anti-tumour activity of DNA methylation inhibitor 5-aza-2'-deoxycytidine is enhanced by the common analgesic paracetamol through induction of oxidative stress. (2021)

First Author: Gleneadie HJ

Attributed to: Validating the PredicTR treatment response classifier for oropharyngeal cancer (PredicTR 2) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.canlet.2020.12.029

PubMed Identifier: 33359448

Publication URI: http://europepmc.org/abstract/MED/33359448

Type: Journal Article/Review

Volume: 501

Parent Publication: Cancer letters

ISSN: 0304-3835